Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Stroke & Vascular Topic Center

News
Incidents of Subarachnoid Hemorrhage on the Rise, Especially in Black Americans
10/28/2022
Brionna Mendoza
Incidences of nontraumatic subarachnoid hemorrhage (SAH) have increased in the United States over the last decade in middle-aged and elderly men, women, and are disproportionately higher in Black patients, according to new study results.
Incidences of nontraumatic subarachnoid hemorrhage (SAH) have increased in the United States over the last decade in middle-aged and elderly men, women, and are disproportionately higher in Black patients, according to new study results.
Incidences of nontraumatic...
10/28/2022
Neurology
News
Smoking Causes Worse Outcomes After Ischemic Stroke, Gene Study Finds
09/29/2022
Jolynn Tumolo
A genetic predisposition to smoking increases the risk of worse recovery from ischemic stroke, according to study results published online ahead of print in Neurology. “Our results provide genetic support for the theory that smoking causes...
A genetic predisposition to smoking increases the risk of worse recovery from ischemic stroke, according to study results published online ahead of print in Neurology. “Our results provide genetic support for the theory that smoking causes...
A genetic predisposition to...
09/29/2022
Neurology
News
Remote Ischemic Conditioning Associated With Better Neurologic Function After Stroke
08/29/2022
Jolynn Tumolo
Remote ischemic conditioning in adults with acute moderate ischemic stroke significantly increased the likelihood of excellent neurologic function at 90 days compared with usual care, according to a study published in JAMA. Remote ischemic...
Remote ischemic conditioning in adults with acute moderate ischemic stroke significantly increased the likelihood of excellent neurologic function at 90 days compared with usual care, according to a study published in JAMA. Remote ischemic...
Remote ischemic conditioning in...
08/29/2022
Neurology
News
COVID-19 May Accelerate Brain Aging, Increase Neurological Risk
08/23/2022
Jolynn Tumolo
The consequences of COVID-19 infection appear to include a predisposition to irreversible neurological conditions, an increased likelihood of stroke, and the potential for chronic brain lesions that can lead to microbleeds, according to a...
The consequences of COVID-19 infection appear to include a predisposition to irreversible neurological conditions, an increased likelihood of stroke, and the potential for chronic brain lesions that can lead to microbleeds, according to a...
The consequences of COVID-19...
08/23/2022
Neurology
News
Heart-Healthy Lifestyle Offsets Genetic Stroke Risk
07/27/2022
Jolynn Tumolo
A healthy cardiovascular lifestyle at midlife can reduce the risk of stroke in individuals with high genetic risk by as much as 43%, according to study findings published online in the Journal of the American Heart Association.
A healthy cardiovascular lifestyle at midlife can reduce the risk of stroke in individuals with high genetic risk by as much as 43%, according to study findings published online in the Journal of the American Heart Association.
A healthy cardiovascular...
07/27/2022
Neurology
News
Rising Depressive Symptoms May Foreshadow Stroke
07/19/2022
Jolynn Tumolo
Increasing depressive symptoms may be a sign of incident stroke, suggest new findings published online ahead of print in the journal Neurology.
Increasing depressive symptoms may be a sign of incident stroke, suggest new findings published online ahead of print in the journal Neurology.
Increasing depressive symptoms...
07/19/2022
Neurology
News
Easy-to-Administer Tenecteplase Reasonable Alternative to Alteplase for Acute Ischemic Stroke
07/13/2022
Jolynn Tumolo
Intravenous tenecteplase is a reasonable alternative to alteplase for the treatment of acute ischemic stroke in all patients who meet standard criteria for thrombolysis, according to study results published in The Lancet.
Intravenous tenecteplase is a reasonable alternative to alteplase for the treatment of acute ischemic stroke in all patients who meet standard criteria for thrombolysis, according to study results published in The Lancet.
Intravenous tenecteplase is a...
07/13/2022
Neurology
Dcotor conducting telehealth appointment.
Quiz
How accurate are neurological diagnoses via telemedicine?
06/23/2022
Take the quiz now to test your knowledge!
Take the quiz now to test your knowledge!
Take the quiz now to test your...
06/23/2022
Neurology
News
RAAS Inhibitors May Lower Risk of Intracranial Aneurysm Rupture
06/15/2022
Jolynn Tumolo
Renin-angiotensin-aldosterone system (RAAS) inhibitors were linked with a significant decreased rupture risk in patients with hypertension and intracranial aneurysms, according to findings from a retrospective study published in Hypertension.
Renin-angiotensin-aldosterone system (RAAS) inhibitors were linked with a significant decreased rupture risk in patients with hypertension and intracranial aneurysms, according to findings from a retrospective study published in Hypertension.
Renin-angiotensin-aldosterone...
06/15/2022
Neurology
Conference Coverage
ESOC 2022: Trial and Research Reviews
05/23/2022
Amrou Sarraj, MD, highlights the RACECAT and PEACH trials as well as showcases information regarding the benefits of flying intervention teams and intraventricular fibrinolysis.
Amrou Sarraj, MD, highlights the RACECAT and PEACH trials as well as showcases information regarding the benefits of flying intervention teams and intraventricular fibrinolysis.
Amrou Sarraj, MD, highlights the...
05/23/2022
Neurology

Advertisement

Advertisement

News

brain waves
News
High-Dose Statins May Not Benefit Patients With Mild Ischemic Stroke
08/08/2024
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose...
08/08/2024
Neurology
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
News
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
07/22/2024
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was...
07/22/2024
Neurology
A brain puzzle against an orange background
News
Prestroke Antiplatelet Therapy Linked With Symptomatic Intracerebral Hemorrhage After Thrombolysis
06/10/2024
Jolynn Tumolo
Prestroke single and dual antiplatelet therapy are associated with an increased risk of symptomatic intracerebral hemorrhage after treatment with intravenous alteplase for acute ischemic stroke.
Prestroke single and dual antiplatelet therapy are associated with an increased risk of symptomatic intracerebral hemorrhage after treatment with intravenous alteplase for acute ischemic stroke.
Prestroke single and dual...
06/10/2024
Neurology
Tirofiban After Acute Ischemic Stroke Eases Early Neurological Deterioration
News
Tirofiban After Acute Ischemic Stroke Eases Early Neurological Deterioration
06/04/2024
Jolynn Tumolo
Intravenous tirofiban decreased the risk of early neurological deterioration in patients with acute noncardioembolic stroke without an increased risk of symptomatic intracerebral hemorrhage or systematic bleeding, according to study results...
Intravenous tirofiban decreased the risk of early neurological deterioration in patients with acute noncardioembolic stroke without an increased risk of symptomatic intracerebral hemorrhage or systematic bleeding, according to study results...
Intravenous tirofiban decreased...
06/04/2024
Neurology
No Significant Difference Between Anticoagulants, Antiplatelets in Preventing Events After Cervical Artery Dissection
News
No Significant Difference Between Anticoagulants, Antiplatelets in Preventing Events After Cervical Artery Dissection
06/03/2024
Jolynn Tumolo
Anticoagulation therapy in patients with cervical artery dissection was associated with a lower combined rate of 90-day ischemic stroke, major bleeding, or death compared with antiplatelet therapy, according to results published in JAMA...
Anticoagulation therapy in patients with cervical artery dissection was associated with a lower combined rate of 90-day ischemic stroke, major bleeding, or death compared with antiplatelet therapy, according to results published in JAMA...
Anticoagulation therapy in...
06/03/2024
Neurology
profile of head with heart over brain region
News
Any Level of Leisure-Time Physical Activity Aids in Stroke Prevention
04/25/2024
Jolynn Tumolo
Any amount of leisure-time physical activity helps to lower the risk of stroke compared with inactivity, according to a systematic review and meta-analysis published in the Journal of Neurology, Neurosurgery & Psychiatry.
Any amount of leisure-time physical activity helps to lower the risk of stroke compared with inactivity, according to a systematic review and meta-analysis published in the Journal of Neurology, Neurosurgery & Psychiatry.
Any amount of leisure-time...
04/25/2024
Neurology
a depiction of a cross section of a brain and spinal cord
News
Study Finds No Elevated Stroke Risk Days After COVID-19 Vaccination
04/12/2024
Jolynn Tumolo
COVID-19 vaccination does not appear to be associated with an increased risk of stroke in US older adults in the early days following administration, according to a study published in JAMA.
COVID-19 vaccination does not appear to be associated with an increased risk of stroke in US older adults in the early days following administration, according to a study published in JAMA.
COVID-19 vaccination does not...
04/12/2024
Neurology
Brain health
News
Hotter Outdoor Temps Raise Acute Ischemic Stroke Risk for Up to 10 Hours
03/18/2024
Jolynn Tumolo
Exposure to high temperatures was associated with an increased risk of acute ischemic stroke (AIS) onset at an hourly level, according to results from national case-crossover study in China published in JAMA Network Open.
Exposure to high temperatures was associated with an increased risk of acute ischemic stroke (AIS) onset at an hourly level, according to results from national case-crossover study in China published in JAMA Network Open.
Exposure to high temperatures...
03/18/2024
Neurology
Early venous filling
Stroke Research
Arterial Connections Improve Treatment Outcomes Following Stroke
02/26/2024

University of Zurich News

University of Zurich News
Researchers have demonstrated that the outcome of stroke treatments depends on the collateral network. Collaterals are blood vessels that cross-connect adjacent arterial trees, providing potential detour networks in case of a vascular...
Researchers have demonstrated that the outcome of stroke treatments depends on the collateral network. Collaterals are blood vessels that cross-connect adjacent arterial trees, providing potential detour networks in case of a vascular...
Researchers have demonstrated...
02/26/2024
Cath Lab Digest
News
Allogeneic stem cell therapy for ischemic stroke is safe, but is it effective?
02/13/2024
Jolynn Tumolo
Intravenous allogeneic stem cell therapy within 18 to 36 hours of ischemic stroke onset was safe but did not improve short-term outcomes compared with placebo, according to study results from a phase 2/3 trial published in JAMA Neurology.
Intravenous allogeneic stem cell therapy within 18 to 36 hours of ischemic stroke onset was safe but did not improve short-term outcomes compared with placebo, according to study results from a phase 2/3 trial published in JAMA Neurology.
Intravenous allogeneic stem cell...
02/13/2024
Neurology
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
News
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
08/08/2024
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive...
08/08/2024
Neurology
brain waves
News
High-Dose Statins May Not Benefit Patients With Mild Ischemic Stroke
08/08/2024
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose...
08/08/2024
Neurology
An illustration of a healthcare provider conducting a telehealth appointment
News
Teleneurology Visits Acceptable to Patients Across Neurologic Conditions
08/05/2024
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic...
08/05/2024
Neurology
The US Food and Drug Administration headquarters sign.
News
DMD Gene Therapy Indication Expanded to Include Boys 4 and Older
08/01/2024
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an...
08/01/2024
Neurology
A person walks down a boarded path with sunlight and trees in the background
News
Backward Walking Speed Reserve Reflects Disease Severity in Patients With MS
07/30/2024
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve,...
07/30/2024
Neurology
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
News
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
07/29/2024
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod...
07/29/2024
Neurology
A middle-aged male running
News
Moderate Physical Activity May Mitigate ALS Risk for Male Patients
07/25/2024
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in...
07/25/2024
Neurology
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
News
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
07/23/2024
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug...
07/23/2024
Neurology
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
News
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
07/22/2024
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was...
07/22/2024
Neurology
a hand breaks a wooden human figurine in half
News
Atogepant Reduces Migraine Days in Patients With Pain Medication Overuse
07/18/2024
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related...
07/18/2024
Neurology

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement